e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Fabry disease
Recent news which mentions Fabry disease
Cannabis Triumphs Where Pain Meds Failed: A Case Study In Fabry Disease
December 08, 2023
Tags
Health Care
Biotech
Cannabis
From
Benzinga
4D Molecular Shares Updated Data From Fabry Disease Trial
February 09, 2022
Tickers
FDMT
Tags
Benzinga
Small Cap
Briefs
From
Benzinga
After Fabry Trial Setback, Avrobio Hopes Rebound With Lysosomal Storage Disorder Data
February 09, 2022
Tickers
AVRO
Tags
Biotech
AVRO
Health Care
From
Benzinga
Sangamo Therapeutics Shares Updated Interim Data From Fabry Disease Gene Therapy Trial
February 08, 2022
Tickers
SGMO
Tags
Health Care
Biotech
Briefs
From
Benzinga
Why Avrobio's Shares Are Plunging Today
January 04, 2022
Tickers
AVRO
Tags
Movers
Earnings
Trading Ideas
From
Benzinga
Freeline Therapeutics Touts Encouraging Data From Fabry Disease Program
November 10, 2021
Tickers
FRLN
Tags
Phase 1 Trial
News
Market News
From
Benzinga
Why Did Sangamo Stock Jump 20% Today?
November 04, 2021
Tickers
SGMO
Tags
Benzinga
Small Cap
Briefs
From
Benzinga
4D Molecular's Fabry Disease Candidate Shows Early Proof-Of-Concept
October 26, 2021
Tickers
FDMT
Tags
Briefs
Biotech
Health Care
From
Benzinga
Amicus's Fabry Disease Medicine Gets European Approval For Use In Adolescents
August 02, 2021
Tickers
FOLD
Tags
Market News
News
General
From
Benzinga
Protalix Stock Is Trading Higher On Meeting Request To FDA For Fabry Disease Candidate Application
August 02, 2021
Tickers
PLX
Tags
News
Market News
Fabry disease
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.